Hygea Medical Technology

Hygea Medical Technology is a Beijing-based medical device company focused on minimally invasive tumor interventional therapy and cryomedicine, founded in 2010 . It operates the Beijing Key Laboratory of Low-Temperature Biomedical Engineering and a post-doctoral research workstation, and has developed what it describes as the world's first system integrating deep-low-temperature cryotherapy with high-intensity thermal therapy . The company positions itself as an integrated interventional oncology platform, having raised a Series C+ round in 2021 exclusively led by Gaorong Ventures and a Series D round in early 2023 led by IN Capital, with Gaorong Ventures also making follow-on investments in the later round . As of early 2023, the D-round proceeds were earmarked for market and channel expansion alongside pipeline R&D and commercialization .